ChartMill assigns a fundamental rating of 2 / 10 to CORV.
ChartMill assigns a valuation rating of 0 / 10 to Correvio Pharma Corp (CORV). This can be considered as Overvalued.
Correvio Pharma Corp (CORV) has a profitability rating of 2 / 10.
The Earnings per Share (EPS) of Correvio Pharma Corp (CORV) is expected to grow by 16.46% in the next year.
The dividend rating of Correvio Pharma Corp (CORV) is 0 / 10 and the dividend payout ratio is 0%.